Global Clinical Trials Market Insights, Forecast to 2029

Publisher Name :
Date: 08-Aug-2023
No. of pages: 111
Inquire Before Buying

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial - their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.

Market Analysis and Insights: Global Clinical Trials Market

The global Clinical Trials market is projected to grow from US$ 48890 million in 2023 to US$ 62370 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period.

The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.

Report Includes

This report presents an overview of global market for Clinical Trials market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Clinical Trials, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical Trials, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clinical Trials revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Clinical Trials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Clinical Trials revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Quintiles IMS, Paraxel International Corporation, Charles River Laboratories, ICON plc, SGS SA, Pharmaceutical Product Development, LLC, Wuxi AppTec Inc., PRA Health Sciences and Chiltern International Ltd., etc.

By Company

- Quintiles IMS

- Paraxel International Corporation

- Charles River Laboratories

- ICON plc

- SGS SA

- Pharmaceutical Product Development, LLC

- Wuxi AppTec Inc.

- PRA Health Sciences

- Chiltern International Ltd.

- INC Research

Segment by Type

- Phase I

- Phase II

- Phase III

- Phase IV

Segment by Application

- Interventional

- Observational

- Expanded Access

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Clinical Trials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Clinical Trials companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trials revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Clinical Trials Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trials Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global Clinical Trials Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Interventional
1.3.3 Observational
1.3.4 Expanded Access
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trials Market Perspective (2018-2029)
2.2 Global Clinical Trials Growth Trends by Region
2.2.1 Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trials Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trials Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trials Market Dynamics
2.3.1 Clinical Trials Industry Trends
2.3.2 Clinical Trials Market Drivers
2.3.3 Clinical Trials Market Challenges
2.3.4 Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Clinical Trials by Players
3.1.1 Global Clinical Trials Revenue by Players (2018-2023)
3.1.2 Global Clinical Trials Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Clinical Trials, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Clinical Trials Market Concentration Ratio
3.4.1 Global Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials Revenue in 2022
3.5 Global Key Players of Clinical Trials Head office and Area Served
3.6 Global Key Players of Clinical Trials, Product and Application
3.7 Global Key Players of Clinical Trials, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trials Breakdown Data by Type
4.1 Global Clinical Trials Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trials Forecasted Market Size by Type (2024-2029)
5 Clinical Trials Breakdown Data by Application
5.1 Global Clinical Trials Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trials Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trials Market Size (2018-2029)
6.2 North America Clinical Trials Market Size by Type
6.2.1 North America Clinical Trials Market Size by Type (2018-2023)
6.2.2 North America Clinical Trials Market Size by Type (2024-2029)
6.2.3 North America Clinical Trials Market Share by Type (2018-2029)
6.3 North America Clinical Trials Market Size by Application
6.3.1 North America Clinical Trials Market Size by Application (2018-2023)
6.3.2 North America Clinical Trials Market Size by Application (2024-2029)
6.3.3 North America Clinical Trials Market Share by Application (2018-2029)
6.4 North America Clinical Trials Market Size by Country
6.4.1 North America Clinical Trials Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Clinical Trials Market Size by Country (2018-2023)
6.4.3 North America Clinical Trials Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Clinical Trials Market Size (2018-2029)
7.2 Europe Clinical Trials Market Size by Type
7.2.1 Europe Clinical Trials Market Size by Type (2018-2023)
7.2.2 Europe Clinical Trials Market Size by Type (2024-2029)
7.2.3 Europe Clinical Trials Market Share by Type (2018-2029)
7.3 Europe Clinical Trials Market Size by Application
7.3.1 Europe Clinical Trials Market Size by Application (2018-2023)
7.3.2 Europe Clinical Trials Market Size by Application (2024-2029)
7.3.3 Europe Clinical Trials Market Share by Application (2018-2029)
7.4 Europe Clinical Trials Market Size by Country
7.4.1 Europe Clinical Trials Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Clinical Trials Market Size by Country (2018-2023)
7.4.3 Europe Clinical Trials Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Clinical Trials Market Size (2018-2029)
8.2 China Clinical Trials Market Size by Type
8.2.1 China Clinical Trials Market Size by Type (2018-2023)
8.2.2 China Clinical Trials Market Size by Type (2024-2029)
8.2.3 China Clinical Trials Market Share by Type (2018-2029)
8.3 China Clinical Trials Market Size by Application
8.3.1 China Clinical Trials Market Size by Application (2018-2023)
8.3.2 China Clinical Trials Market Size by Application (2024-2029)
8.3.3 China Clinical Trials Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Clinical Trials Market Size (2018-2029)
9.2 Asia Clinical Trials Market Size by Type
9.2.1 Asia Clinical Trials Market Size by Type (2018-2023)
9.2.2 Asia Clinical Trials Market Size by Type (2024-2029)
9.2.3 Asia Clinical Trials Market Share by Type (2018-2029)
9.3 Asia Clinical Trials Market Size by Application
9.3.1 Asia Clinical Trials Market Size by Application (2018-2023)
9.3.2 Asia Clinical Trials Market Size by Application (2024-2029)
9.3.3 Asia Clinical Trials Market Share by Application (2018-2029)
9.4 Asia Clinical Trials Market Size by Region
9.4.1 Asia Clinical Trials Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Clinical Trials Market Size by Region (2018-2023)
9.4.3 Asia Clinical Trials Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Clinical Trials Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Clinical Trials Market Size by Type
10.2.1 Middle East, Africa, and Latin America Clinical Trials Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Clinical Trials Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Clinical Trials Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Clinical Trials Market Size by Application
10.3.1 Middle East, Africa, and Latin America Clinical Trials Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Clinical Trials Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Clinical Trials Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Clinical Trials Market Size by Country
10.4.1 Middle East, Africa, and Latin America Clinical Trials Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Clinical Trials Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Clinical Trials Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Quintiles IMS
11.1.1 Quintiles IMS Company Details
11.1.2 Quintiles IMS Business Overview
11.1.3 Quintiles IMS Clinical Trials Introduction
11.1.4 Quintiles IMS Revenue in Clinical Trials Business (2018-2023)
11.1.5 Quintiles IMS Recent Developments
11.2 Paraxel International Corporation
11.2.1 Paraxel International Corporation Company Details
11.2.2 Paraxel International Corporation Business Overview
11.2.3 Paraxel International Corporation Clinical Trials Introduction
11.2.4 Paraxel International Corporation Revenue in Clinical Trials Business (2018-2023)
11.2.5 Paraxel International Corporation Recent Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Clinical Trials Introduction
11.3.4 Charles River Laboratories Revenue in Clinical Trials Business (2018-2023)
11.3.5 Charles River Laboratories Recent Developments
11.4 ICON plc
11.4.1 ICON plc Company Details
11.4.2 ICON plc Business Overview
11.4.3 ICON plc Clinical Trials Introduction
11.4.4 ICON plc Revenue in Clinical Trials Business (2018-2023)
11.4.5 ICON plc Recent Developments
11.5 SGS SA
11.5.1 SGS SA Company Details
11.5.2 SGS SA Business Overview
11.5.3 SGS SA Clinical Trials Introduction
11.5.4 SGS SA Revenue in Clinical Trials Business (2018-2023)
11.5.5 SGS SA Recent Developments
11.6 Pharmaceutical Product Development, LLC
11.6.1 Pharmaceutical Product Development, LLC Company Details
11.6.2 Pharmaceutical Product Development, LLC Business Overview
11.6.3 Pharmaceutical Product Development, LLC Clinical Trials Introduction
11.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2018-2023)
11.6.5 Pharmaceutical Product Development, LLC Recent Developments
11.7 Wuxi AppTec Inc.
11.7.1 Wuxi AppTec Inc. Company Details
11.7.2 Wuxi AppTec Inc. Business Overview
11.7.3 Wuxi AppTec Inc. Clinical Trials Introduction
11.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials Business (2018-2023)
11.7.5 Wuxi AppTec Inc. Recent Developments
11.8 PRA Health Sciences
11.8.1 PRA Health Sciences Company Details
11.8.2 PRA Health Sciences Business Overview
11.8.3 PRA Health Sciences Clinical Trials Introduction
11.8.4 PRA Health Sciences Revenue in Clinical Trials Business (2018-2023)
11.8.5 PRA Health Sciences Recent Developments
11.9 Chiltern International Ltd.
11.9.1 Chiltern International Ltd. Company Details
11.9.2 Chiltern International Ltd. Business Overview
11.9.3 Chiltern International Ltd. Clinical Trials Introduction
11.9.4 Chiltern International Ltd. Revenue in Clinical Trials Business (2018-2023)
11.9.5 Chiltern International Ltd. Recent Developments
11.10 INC Research
11.10.1 INC Research Company Details
11.10.2 INC Research Business Overview
11.10.3 INC Research Clinical Trials Introduction
11.10.4 INC Research Revenue in Clinical Trials Business (2018-2023)
11.10.5 INC Research Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Clinical Trials Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global Clinical Trials Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Clinical Trials Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Clinical Trials Market Share by Region (2018-2023)
Table 10. Global Clinical Trials Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Clinical Trials Market Share by Region (2024-2029)
Table 12. Clinical Trials Market Trends
Table 13. Clinical Trials Market Drivers
Table 14. Clinical Trials Market Challenges
Table 15. Clinical Trials Market Restraints
Table 16. Global Clinical Trials Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Clinical Trials Revenue Share by Players (2018-2023)
Table 18. Global Top Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials as of 2022)
Table 19. Global Clinical Trials Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Clinical Trials Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Clinical Trials, Headquarters and Area Served
Table 22. Global Key Players of Clinical Trials, Product and Application
Table 23. Global Key Players of Clinical Trials, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Clinical Trials Revenue Market Share by Type (2018-2023)
Table 27. Global Clinical Trials Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Clinical Trials Revenue Market Share by Type (2024-2029)
Table 29. Global Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Clinical Trials Revenue Share by Application (2018-2023)
Table 31. Global Clinical Trials Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Clinical Trials Revenue Share by Application (2024-2029)
Table 33. North America Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Clinical Trials Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Clinical Trials Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Clinical Trials Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Clinical Trials Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Clinical Trials Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Clinical Trials Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Clinical Trials Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Clinical Trials Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Clinical Trials Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Clinical Trials Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Clinical Trials Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Clinical Trials Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Clinical Trials Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Clinical Trials Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Clinical Trials Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Clinical Trials Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Clinical Trials Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Clinical Trials Market Size by Country (2024-2029) & (US$ Million)
Table 65. Quintiles IMS Company Details
Table 66. Quintiles IMS Business Overview
Table 67. Quintiles IMS Clinical Trials Product
Table 68. Quintiles IMS Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 69. Quintiles IMS Recent Developments
Table 70. Paraxel International Corporation Company Details
Table 71. Paraxel International Corporation Business Overview
Table 72. Paraxel International Corporation Clinical Trials Product
Table 73. Paraxel International Corporation Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 74. Paraxel International Corporation Recent Developments
Table 75. Charles River Laboratories Company Details
Table 76. Charles River Laboratories Business Overview
Table 77. Charles River Laboratories Clinical Trials Product
Table 78. Charles River Laboratories Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 79. Charles River Laboratories Recent Developments
Table 80. ICON plc Company Details
Table 81. ICON plc Business Overview
Table 82. ICON plc Clinical Trials Product
Table 83. ICON plc Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 84. ICON plc Recent Developments
Table 85. SGS SA Company Details
Table 86. SGS SA Business Overview
Table 87. SGS SA Clinical Trials Product
Table 88. SGS SA Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 89. SGS SA Recent Developments
Table 90. Pharmaceutical Product Development, LLC Company Details
Table 91. Pharmaceutical Product Development, LLC Business Overview
Table 92. Pharmaceutical Product Development, LLC Clinical Trials Product
Table 93. Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 94. Pharmaceutical Product Development, LLC Recent Developments
Table 95. Wuxi AppTec Inc. Company Details
Table 96. Wuxi AppTec Inc. Business Overview
Table 97. Wuxi AppTec Inc. Clinical Trials Product
Table 98. Wuxi AppTec Inc. Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 99. Wuxi AppTec Inc. Recent Developments
Table 100. PRA Health Sciences Company Details
Table 101. PRA Health Sciences Business Overview
Table 102. PRA Health Sciences Clinical Trials Product
Table 103. PRA Health Sciences Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 104. PRA Health Sciences Recent Developments
Table 105. Chiltern International Ltd. Company Details
Table 106. Chiltern International Ltd. Business Overview
Table 107. Chiltern International Ltd. Clinical Trials Product
Table 108. Chiltern International Ltd. Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 109. Chiltern International Ltd. Recent Developments
Table 110. INC Research Company Details
Table 111. INC Research Business Overview
Table 112. INC Research Clinical Trials Product
Table 113. INC Research Revenue in Clinical Trials Business (2018-2023) & (US$ Million)
Table 114. INC Research Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Trials Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Clinical Trials Market Share by Type: 2022 VS 2029
Figure 3. Phase I Features
Figure 4. Phase II Features
Figure 5. Phase III Features
Figure 6. Phase IV Features
Figure 7. Global Clinical Trials Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Clinical Trials Market Share by Application: 2022 VS 2029
Figure 9. Interventional Case Studies
Figure 10. Observational Case Studies
Figure 11. Expanded Access Case Studies
Figure 12. Clinical Trials Report Years Considered
Figure 13. Global Clinical Trials Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Clinical Trials Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Clinical Trials Market Share by Region: 2022 VS 2029
Figure 16. Global Clinical Trials Market Share by Players in 2022
Figure 17. Global Top Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Clinical Trials Revenue in 2022
Figure 19. North America Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Clinical Trials Market Share by Type (2018-2029)
Figure 21. North America Clinical Trials Market Share by Application (2018-2029)
Figure 22. North America Clinical Trials Market Share by Country (2018-2029)
Figure 23. United States Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Clinical Trials Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Clinical Trials Market Share by Type (2018-2029)
Figure 27. Europe Clinical Trials Market Share by Application (2018-2029)
Figure 28. Europe Clinical Trials Market Share by Country (2018-2029)
Figure 29. Germany Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Clinical Trials Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Clinical Trials Market Share by Type (2018-2029)
Figure 37. China Clinical Trials Market Share by Application (2018-2029)
Figure 38. Asia Clinical Trials Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Clinical Trials Market Share by Type (2018-2029)
Figure 40. Asia Clinical Trials Market Share by Application (2018-2029)
Figure 41. Asia Clinical Trials Market Share by Region (2018-2029)
Figure 42. Japan Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Clinical Trials Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Clinical Trials Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Clinical Trials Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Clinical Trials Market Share by Country (2018-2029)
Figure 52. Brazil Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Clinical Trials Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Quintiles IMS Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 59. Paraxel International Corporation Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 60. Charles River Laboratories Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 61. ICON plc Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 62. SGS SA Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 63. Pharmaceutical Product Development, LLC Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 64. Wuxi AppTec Inc. Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 65. PRA Health Sciences Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 66. Chiltern International Ltd. Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 67. INC Research Revenue Growth Rate in Clinical Trials Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global Clinical Trial Support Services Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 107
    Market Overview of Global Clinical Trial Support Services market: According to our latest research, the global Clinical Trial Support Services market looks promising in the next 5 years. As of 2022, the global Clinical Trial Support Services market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Clinical trial support services are the various services, which pharmaceutical companies use durin......
  • Global Clinical Trial Supplies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Clinical Trial Supplies market: According to our latest research, the global Clinical Trial Supplies market looks promising in the next 5 years. As of 2022, the global Clinical Trial Supplies market was estimated at USD 1939.69 million, and it's anticipated to reach USD 3477.51 million in 2028, with a CAGR of 10.22% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Global Clinical Trial Management System (CTMS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Clinical Trial Management System (CTMS) market: According to our latest research, the global Clinical Trial Management System (CTMS) market looks promising in the next 5 years. As of 2022, the global Clinical Trial Management System (CTMS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a ......
  • Global Bladder Cancer Clinical Trials Market Status and Outlook 2023-2028
    Published: 07-Nov-2023        Price: US 3160 Onwards        Pages: 107
    A clinical trial is a research study that tries to find better ways to prevent, screen for, diagnose, or treat a disease. Clinical trials are an essential part of cancer research. They may provide possible treatment alternatives to patients who have not had success with standard and approved therapies. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Global Forecast to 2028
    Published: 09-Oct-2023        Price: US 4950 Onwards        Pages: 340
    “The clinical trial supplies market is projected to grow at a CAGR of 9.9% during the forecast period of 2023-2028.” The global clinical trial supplies market size is projected to reach USD 6.3 billion by 2028 from USD 3.9 billion in 2023, at a CAGR of 9.9% during the forecast period. Factors such as Increasing number of clinical trials, Growing product pipeline, and Increasing decentralization of clinical trials are likely to have positive impact on the m......
  • Global Clinical Trials Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Oct-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Clinical Trials market: According to our latest research, the global Clinical Trials market looks promising in the next 5 years. As of 2022, the global Clinical Trials market was estimated at USD 29710.78 million, and it's anticipated to reach USD 50447.34 million in 2028, with a CAGR of 9.22% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Clinical Tri......
  • Global Hypoparathyroidism Clinical Trials Market Insights, Forecast to 2029
    Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 74
    Market Analysis and Insights: Global Hypoparathyroidism Clinical Trials Market The global Hypoparathyroidism Clinical Trials market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Hypoparathyroidism Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Th......
  • Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028
    Published: 08-Sep-2023        Price: US 4950 Onwards        Pages: 353
    “Increasing number of drugs in pipeline and rise in number of clinical trials are driving the growth of the clinical trials market.” The global clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing demand for specialized testing services. Companies are increasingly outsourcing specialize......
  • Global Clinical Trials Market Insights, Forecast to 2029
    Published: 08-Aug-2023        Price: US 4900 Onwards        Pages: 111
    Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs